CAPLYTA’s Strong Market Adoption Propels Its Rise as a Leading Antipsychotic Therapy | DelveInsight
Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...
bpHope6h
Bipolar Research & Insights: Genetics, Biological Clocks, Sleep Changes, and More | February 2025
Explore new findings on bipolar disorder, from genetics to sleep patterns, plus emerging treatments and a neuroscientist’s ...
EXCLUSIVE: Alzamend Neuro Says Tesla Dynamic Completes Head Coil To Measure Brain Structure Lithium Levels
Alzamend Neuro, Inc. (NASDAQ:ALZN) announced it had completed the head coil by Tesla Dynamic Coils BV. The development of the ...
Daily5d
Lithium use may Increase Risk of Thyroid and Kidney Dysfunction among patients with bipolar disorder: JAMA
A Chinese retrospective cohort study has found that lithium use in bipolar disorder patients was linked to a higher risk of ...